Denver, CO – May 31, 2018 – SyncHR announced today that Florida Cancer Specialists & Research Institute (FCS), the largest independent privately-held medical oncology and hematology practice in the United States, selected SyncHR's cloud-based people platform to help meet its increasing HR, payroll and benefits management needs. After careful evaluation, SyncHR beat out several well-known Human Capital Management (HCM) Systems, including FCS' incumbent vendor.
Modern Cloud: Unlike most legacy HCM solutions, SyncHR was designed and built from the ground up for the cloud, delivering enterprise-class automation, analytics and true cloud scalability, security and reliability.
Extensibility: SyncHR provides the full spectrum of HR, benefit and payroll management needs in a single, centralized solution along with modern extensibility into virtually any third-party system, delivering greater workflow automation and workforce visibility.
Data Integrity: Since SyncHR never breaks up HR, payroll and benefit management, it provides a true system of record that eliminates manual data entry and discrepancies between systems. Moreover, SyncHR's time-base data model allows administrators to accurately and easily transact in any time period – past, present or future.
Premium Service & Support: A key factor in FCS' decision to change vendors was a lack of timely and expert service and support from its previous well-known HCM vendor. SyncHR provides designated account management support, premium service and even offers internal change management assistance.
SyncHR advances beyond legacy HCM solutions to deliver a next-gen people platform in the cloud that helps growing enterprises make smarter data-driven decisions around their workforce, automate HR administrative tasks, and deliver a more intuitive user experience for employees, managers and executives. SyncHR delivers the full spectrum of HR, payroll and benefits management capabilities along with built-in security, scalability and extensibility into virtually any third-party system.